LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 2 of total 2

Search options

  1. Article ; Online: An international review of the characteristics of viral nucleic acid-amplification testing (NAT) reveals a trend towards the use of smaller pool sizes and individual donation NAT.

    Faddy, Helen M / Osiowy, Carla / Custer, Brian / Busch, Michael / Stramer, Susan L / Dean, Melinda M / Acutt, Jessika / Viennet, Elvina / van de Laar, Thijs / Tsoi, Wai-Chiu / Styles, Claire / Kiely, Phil / Margaritis, Angelo / Kwon, So-Yong / Qiu, Yan / Deng, Xuelian / Lewin, Antoine / Jørgensen, Signe Winther / Erikstrup, Christian /
    Juhl, David / Sauleda, Silvia / Camacho Rodriguez, Bernardo Armando / Soto Coral, Lisbeth Jennifer Catherine / Gaviria García, Paula Andrea / Oota, Sineenart / O'Brien, Sheila F / Wendel, Silvano / Castro, Emma / Navarro Pérez, Laura / Harvala, Heli / Davison, Katy / Reynolds, Claire / Jarvis, Lisa / Grabarczyk, Piotr / Kopacz, Aneta / Łętowska, Magdalena / O'Flaherty, Niamh / Young, Fiona / Williams, Padraig / Burke, Lisa / Chua, Sze Sze / Muylaert, An / Page, Isabel / Jones, Ann / Niederhauser, Christoph / Vermeulen, Marion / Laperche, Syria / Gallian, Pierre / Satake, Masahiro / Addas-Carvalho, Marcelo / Blanco, Sebastián / Gallego, Sandra V / Seltsam, Axel / Weber-Schehl, Marijke / Al-Riyami, Arwa Z / Al Maamari, Khuloud / Alawi, Fatma Ba / Pandey, Hem Chandra / França, Rochele Azevedo / Charlewood, Richard

    Vox sanguinis

    2024  

    Abstract: Background and objectives: Nucleic acid-amplification testing (NAT) is used for screening blood donations/donors for blood-borne viruses. We reviewed global viral NAT characteristics and NAT-yield confirmatory testing used by blood operators.: ... ...

    Abstract Background and objectives: Nucleic acid-amplification testing (NAT) is used for screening blood donations/donors for blood-borne viruses. We reviewed global viral NAT characteristics and NAT-yield confirmatory testing used by blood operators.
    Materials and methods: NAT characteristics and NAT-yield confirmatory testing used during 2019 was surveyed internationally by the International Society of Blood Transfusion Working Party Transfusion-Transmitted Infectious Diseases. Reported characteristics are presented herein.
    Results: NAT was mainly performed under government mandate. Human immunodeficiency virus (HIV), hepatitis C virus (HCV) and hepatitis B virus (HBV) NAT was performed on all donors and donation types, while selective testing was reported for West Nile virus, hepatitis E virus (HEV), and Zika virus. Individual donation NAT was used for HIV, HCV and HBV by ~50% of responders, while HEV was screened in mini-pools by 83% of responders performing HEV NAT. Confirmatory testing for NAT-yield samples was generally performed by NAT on a sample from the same donation or by NAT and serology on samples from the same donation and a follow-up sample.
    Conclusion: In the last decade, there has been a trend towards use of smaller pool sizes or individual donation NAT. We captured characteristics of NAT internationally in 2019 and provide insights into confirmatory testing approaches used for NAT-yields, potentially benefitting blood operators seeking to implement NAT.
    Language English
    Publishing date 2024-03-22
    Publishing country England
    Document type Journal Article
    ZDB-ID 80313-3
    ISSN 1423-0410 ; 0042-9007
    ISSN (online) 1423-0410
    ISSN 0042-9007
    DOI 10.1111/vox.13617
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: International review of blood donation nucleic acid amplification testing.

    Faddy, Helen M / Osiowy, Carla / Custer, Brian / Busch, Michael / Stramer, Susan L / Adesina, Opeyemi / van de Laar, Thijs / Tsoi, Wai-Chiu / Styles, Claire / Kiely, Phil / Margaritis, Angelo / Kwon, So-Yong / Qiu, Yan / Deng, Xuelian / Lewin, Antoine / Jørgensen, Signe Winther / Erikstrup, Christian / Juhl, David / Sauleda, Silvia /
    Camacho Rodriguez, Bernardo Armando / Coral, Lisbeth Jennifer Catherine Soto / Gaviria García, Paula Andrea / Oota, Sineenart / O'Brien, Sheila F / Wendel, Silvano / Castro, Emma / Navarro Pérez, Laura / Harvala, Heli / Davison, Katy / Reynolds, Claire / Jarvis, Lisa / Grabarczyk, Piotr / Kopacz, Aneta / Łętowska, Magdalena / O'Flaherty, Niamh / Young, Fiona / Williams, Padraig / Burke, Lisa / Chua, Sze Sze / Muylaert, An / Page, Isabel / Jones, Ann / Niederhauser, Christoph / Vermeulen, Marion / Laperche, Syria / Gallian, Pierre / Sawadogo, Salam / Satake, Masahiro / Gharehbaghian, Ahmad / Addas-Carvalho, Marcelo / Blanco, Sebastián / Gallego, Sandra V / Seltsam, Axel / Weber-Schehl, Marijke / Al-Riyami, Arwa Z / Al Maamari, Khuloud / Alawi, Fatma Ba / Pandey, Hem Chandra / Mbanya, Dora / França, Rochele Azevedo / Charlewood, Richard

    Vox sanguinis

    2024  Volume 119, Issue 4, Page(s) 315–325

    Abstract: Background and objectives: Nucleic acid amplification testing (NAT), in blood services context, is used for the detection of viral and parasite nucleic acids to reduce transfusion-transmitted infections. This project reviewed NAT for screening blood ... ...

    Abstract Background and objectives: Nucleic acid amplification testing (NAT), in blood services context, is used for the detection of viral and parasite nucleic acids to reduce transfusion-transmitted infections. This project reviewed NAT for screening blood donations globally.
    Materials and methods: A survey on NAT usage, developed by the International Society of Blood Transfusion Working Party on Transfusion-transmitted Infectious Diseases (ISBT WP-TTID), was distributed through ISBT WP-TTID members. Data were analysed using descriptive statistics.
    Results: Forty-three responses were received from 32 countries. Increased adoption of blood donation viral screening by NAT was observed over the past decade. NAT-positive donations were detected for all viruses tested in 2019 (proportion of donations positive by NAT were 0.0099% for human immunodeficiency virus [HIV], 0.0063% for hepatitis C virus [HCV], 0.0247% for hepatitis B virus [HBV], 0.0323% for hepatitis E virus [HEV], 0.0014% for West Nile virus [WNV] and 0.00005% for Zika virus [ZIKV]). Globally, over 3100 NAT-positive donations were identified as NAT yield or solely by NAT in 2019 and over 22,000 since the introduction of NAT, with HBV accounting for over half. NAT-positivity rate was higher in first-time donors for all viruses tested except WNV. During 2019, a small number of participants performed NAT for parasites (Trypanosoma cruzi, Babesia spp., Plasmodium spp.).
    Conclusion: This survey captures current use of blood donation NAT globally. There has been increased NAT usage over the last decade. It is clear that NAT contributes to improving blood transfusion safety globally; however, there is a need to overcome economic barriers for regions/countries not performing NAT.
    MeSH term(s) Humans ; Blood Donation ; Blood Donors ; Hepatitis B/diagnosis ; Hepatitis B virus/genetics ; Nucleic Acid Amplification Techniques ; Nucleic Acids ; Transfusion Reaction ; Zika Virus ; Zika Virus Infection
    Chemical Substances Nucleic Acids
    Language English
    Publishing date 2024-02-23
    Publishing country England
    Document type Journal Article ; Review
    ZDB-ID 80313-3
    ISSN 1423-0410 ; 0042-9007
    ISSN (online) 1423-0410
    ISSN 0042-9007
    DOI 10.1111/vox.13592
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top